PANTHERx Rare, a US-based rare disease specialty pharmacy, announced on Thursday that it has named Bansi Nagji as its new CEO, effective 1 August 2024.

In addition to the new role, Nagji is to continue with his present service as a member of the company's board of directors.

Nagji has over 25 years of leadership experience covering pharma services and supply chain, healthcare technology, and digital platforms. He has held the position of executive chair at PANTHERx Rare from December 2023. He has earlier worked as president, Healthcare at GoodRx, Inc., executive vice president and chief strategy and business development officer at McKesson Corporation. He has an extensive background as a board member for both private and public companies, which includes Change Healthcare, Deloitte, and Parata Systems.